An Unbiased Cell Morphology–Based Screen for New, Biologically Active Small Molecules
Masahiro Tanaka(University of California, San Francisco), Cynthia L. Adams(Cytokinetics (United States)), Daniel Rauh(TU Dortmund University), Eugeni Vaisberg(Cytokinetics (United States)), Kirk C. Hansen(University of Colorado Anschutz Medical Campus), J. K. Trautman(AT&T (United States)), Kevan M. Shokat(Howard Hughes Medical Institute), Chao Zhang(Novartis (China)), Shyam Ramachandani(Cytokinetics (United States)), Raynard L. Bateman, Alma L. Burlingame(University of California, San Francisco)
Cited by 232
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
|Nature Medicine|2015|1.4k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k